BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  DowDuPont Provides Expected Third Quarter 2017 Financial Results, Files Historical Pro Forma Financial Statements

  DowDuPont today filed historical unaudited pro forma financial statements that give effect to the Merger Transaction.

  October 26, 2017

   · 

  10 min read
• Business

  Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update

  Novocure today reported financial results for the three and nine months ended September 30, 2017, highlighting year-over-year and sequential growth in active patients and net revenues.

  October 26, 2017

   · 

  16 min read
• Business

  Lannett to Report Fiscal 2018 First-Quarter Financial Results, Host Conference Call On Monday, November 6

  Lannett Company today announced that it will report financial results for its fiscal 2018 first quarter on Monday, November 6, 2017, after the market closes.

  October 26, 2017

   · 

  1 min read
• Business

  Halyard Health to Webcast Conference Call Discussing Third Quarter 2017 Financial Results

  Halyard Health will webcast its conference call discussing financial results and business highlights for the third quarter 2017 on Wednesday, Nov. 1 at 9 a.m. ET.

  October 26, 2017

   · 

  1 min read
• Lone Star Bio

  CeloNova’s COBRA PzF NanoCoated Coronary Stent Being Studied with 14-day DAPT in High Bleeding Risk Patients

  CeloNova BioSciences today announced that the FDA approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF NCS with 14-day DAPT in complex patients, such as those who are at high bleeding risk.

  October 26, 2017

   · 

  6 min read
• Business

  Alexion Reports Third Quarter 2017 Results

  Alexion Pharmaceuticals, Inc. today announced financial results for the third quarter of 2017.

  October 26, 2017

   · 

  19 min read
• Business

  Medidata Reports Record Third Quarter 2017 Results

  Medidata, the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the third quarter of 2017.

  October 26, 2017

   · 

  21 min read
• Drug Development

  Prometic Receives Clearance From the Swedish Medical Products Agency to Initiate Plasminogen Diabetic Foot Ulcer Phase II Clinical Trial

  Prometic today announced that it has received Swedish MPA CTA approval to commence a Phase II clinical trial of its plasminogen therapy in patients suffering from diabetic foot ulcer.

  October 26, 2017

   · 

  4 min read
• Business

  Advanced Medical Solutions Group and Organogenesis Enter into Patent Out-licensing Agreement

  Advanced Medical Solutions Group plcand Organogenesis today announced the two companies have entered into an out-licensing agreement on a U.S. patent for a collagen-based wound dressing containing Polyhexamethylene Biguanide.

  October 26, 2017

   · 

  3 min read
• Business

  Acceleron to Webcast Third Quarter 2017 Financial Results on November 7, 2017

  Acceleron Pharma Inc. today announced it will host a webcast and conference call on Tuesday, November 7, 2017 at 8:00 a.m. EST to discuss its third quarter 2017 financial results and provide an update on recent clinical development and corporate activities.

  October 26, 2017

   · 

  1 min read